Kezar
Kezar Life Sciences, Inc.
4
0
2
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
He Huang, PhD
First Affiliated Hospital of Zhejiang University
Shared therapeutic areas:
heng Mei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shared therapeutic areas:
Thomas Ortel, MD
Duke University
Shared therapeutic areas:
Xianyun Wang, Doctor
The First Hospital of Hebei Medical University
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Nigel Key, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Hatice N Sen, M.D.
National Eye Institute (NEI)
Shared therapeutic areas:
Roman Hovorka, PhD
University of Cambridge
Shared therapeutic areas:
Bruce Buckingham, MD
Stanford University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP
All 4 trials loaded